Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists01:27

Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists

5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists01:29

Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists

Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists01:28

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists

Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy.  SP binds and activates these...
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids01:21

Chemotherapy-Induced Nausea and Vomiting: Cannabinoids

Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A case report: false hCG trail: dysgerminoma imitates gestational trophoblastic disease.

AJOG global reports·2026
Same author

Clinically relevant histopathological features and biomarkers in endometrial cancer.

Ceska gynekologie·2026
Same author

Ectopic pregnancy management and treatment strategies: A nationwide survey of Czech gynecological facilities.

Women's health (London, England)·2026
Same author

The advantages and limitations of the new FIGO 2023 staging system for endometrial carcinoma from the perspective of the clinician and pathologist.

Ceskoslovenska patologie·2026
Same author

Significance of positive excision margins in therapy of high-grade vulvar precancerosis - analysis of own data and literary review.

Ceska gynekologie·2026
Same author

The Effect of Human Papillomavirus Infection on Pregnancy Outcomes: A Scoping Review.

Diagnostics (Basel, Switzerland)·2026

Related Experiment Video

Updated: Jun 12, 2026

Acupoint Application Combined with Acupressure as an Adjunctive Therapy for Chemotherapy-Induced Nausea and Vomiting
05:56

Acupoint Application Combined with Acupressure as an Adjunctive Therapy for Chemotherapy-Induced Nausea and Vomiting

Published on: June 21, 2024

[Chemotherapy during pregnancy].

Michael J Halaska1, K Suchová, I Spálová

  • 1Gynekologicko-porodnická klinika 2. LF UK a FN, Praha. mhalaska@centrum.cz

Ceska Gynekologie
|June 23, 2010
PubMed
Summary
This summary is machine-generated.

Chemotherapy during pregnancy, including cisplatin, carboplatin, and taxanes, can be administered safely with close monitoring. Long-term follow-up is essential for assessing outcomes in both mother and child.

Related Experiment Videos

Last Updated: Jun 12, 2026

Acupoint Application Combined with Acupressure as an Adjunctive Therapy for Chemotherapy-Induced Nausea and Vomiting
05:56

Acupoint Application Combined with Acupressure as an Adjunctive Therapy for Chemotherapy-Induced Nausea and Vomiting

Published on: June 21, 2024

Area of Science:

  • Obstetrics and Gynecology
  • Perinatology
  • Medical Oncology

Context:

  • Pregnancy presents unique challenges for cancer treatment.
  • Chemotherapy administration during gestation requires careful consideration of maternal and fetal well-being.
  • Limited data exists on the safety and efficacy of specific chemotherapeutic agents during pregnancy.

Purpose:

  • To review and summarize existing literature on chemotherapy use in pregnant patients.
  • To evaluate the outcomes associated with specific chemotherapeutic agents, including cisplatin, carboplatin, and taxanes.
  • To provide guidance on the management of cancer during pregnancy.

Summary:

  • A literature search (1980-2009) identified cases of cisplatin (38), carboplatin (8), and taxane (21) administration during pregnancy.
  • Carboplatin use resulted in normal neonatal outcomes in all reported cases.
  • Data on cisplatin and taxane use during pregnancy, while limited, suggests potential for administration under strict supervision.

Impact:

  • Highlights the feasibility of chemotherapy in select pregnant cancer patients.
  • Emphasizes the critical need for multidisciplinary care and long-term follow-up.
  • Informs clinical decision-making for oncologists and obstetricians managing pregnancy with cancer.